Pharmacovigilance - Technological Advancements, Recent Developments and Innovations.

IF 0.7 Q4 PHARMACOLOGY & PHARMACY Current drug safety Pub Date : 2025-01-01 DOI:10.2174/0115748863356840250112181406
Virendra S Gomase
{"title":"Pharmacovigilance - Technological Advancements, Recent Developments and Innovations.","authors":"Virendra S Gomase","doi":"10.2174/0115748863356840250112181406","DOIUrl":null,"url":null,"abstract":"<p><p>Pharmacovigilance is an important subject in medicine and healthcare, which aims to prevent side effects and other drug-related problems by identifying, evaluating, understanding, and avoiding them. Its main objectives are ensuring that a drug's benefits balance its hazards and improving patient safety. Within medicine and healthcare, pharmacovigilance is an essential subject that focuses on identifying, evaluating, comprehending, and preventing side effects or any other issues associated with drugs. Its main objective is to improve patient safety and ensure a drug's advantages exceed its drawbacks. Pharmacovigilance has evolved significantly as a result of technological advancements, enabling more efficient medication, safety monitoring, and management. The combination of machine learning (ML) with artificial intelligence (AI) for data analysis, adverse reaction prediction, and signal detection, electronic health records (EHRs), and mobile health (mHealth) applications have enhanced real-time data collecting and expedited the reporting of adverse drug reactions (ADRs). Pharmacovigilance plays an important role which focuses on detecting, assessing, comprehending, and averting adverse medication reactions. Making sure a drug's advantages outweigh its disadvantages is its main objective to improve patient safety. Pharmacovigilance, which balances patient safety, efficacy, and regulatory compliance in clinical trials, is necessary to promote the safe and effective use of drugs.</p>","PeriodicalId":10777,"journal":{"name":"Current drug safety","volume":" ","pages":"423-449"},"PeriodicalIF":0.7000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug safety","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115748863356840250112181406","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Pharmacovigilance is an important subject in medicine and healthcare, which aims to prevent side effects and other drug-related problems by identifying, evaluating, understanding, and avoiding them. Its main objectives are ensuring that a drug's benefits balance its hazards and improving patient safety. Within medicine and healthcare, pharmacovigilance is an essential subject that focuses on identifying, evaluating, comprehending, and preventing side effects or any other issues associated with drugs. Its main objective is to improve patient safety and ensure a drug's advantages exceed its drawbacks. Pharmacovigilance has evolved significantly as a result of technological advancements, enabling more efficient medication, safety monitoring, and management. The combination of machine learning (ML) with artificial intelligence (AI) for data analysis, adverse reaction prediction, and signal detection, electronic health records (EHRs), and mobile health (mHealth) applications have enhanced real-time data collecting and expedited the reporting of adverse drug reactions (ADRs). Pharmacovigilance plays an important role which focuses on detecting, assessing, comprehending, and averting adverse medication reactions. Making sure a drug's advantages outweigh its disadvantages is its main objective to improve patient safety. Pharmacovigilance, which balances patient safety, efficacy, and regulatory compliance in clinical trials, is necessary to promote the safe and effective use of drugs.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
药物警戒-技术进步,最新发展和创新。
药物警戒是医学和卫生保健中的一门重要学科,旨在通过识别、评估、了解和避免药物副作用和其他与药物有关的问题来预防它们。其主要目标是确保药物的益处平衡其危害并改善患者安全。在医学和医疗保健中,药物警戒是一门重要的学科,其重点是识别、评估、理解和预防与药物相关的副作用或任何其他问题。其主要目标是提高患者的安全性,并确保药物的优点大于缺点。由于技术进步,药物警戒已经有了显著的发展,使更有效的用药、安全监测和管理成为可能。机器学习(ML)与人工智能(AI)相结合,用于数据分析、不良反应预测和信号检测、电子健康记录(EHRs)和移动健康(mHealth)应用程序,增强了实时数据收集并加快了药物不良反应(adr)的报告。药物警戒在发现、评估、理解和避免药物不良反应方面起着重要作用。确保药物的优点大于缺点是提高患者安全的主要目标。在临床试验中平衡患者安全、疗效和法规遵从性的药物警戒对于促进药物的安全和有效使用是必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current drug safety
Current drug safety PHARMACOLOGY & PHARMACY-
CiteScore
2.10
自引率
0.00%
发文量
112
期刊介绍: Current Drug Safety publishes frontier articles on all the latest advances on drug safety. The journal aims to publish the highest quality research articles, reviews and case reports in the field. Topics covered include: adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, post-marketing surveillance. The journal is essential reading for all researchers and clinicians involved in drug safety.
期刊最新文献
Neurological Complications of Prolonged Metronidazole Therapy: A Case of Reversible Encephalopathy. Different Therapeutic Doses of Sertraline Induce Liver Damage in Male Rats. Linezolid-Induced Pancytopenia with Hyponatremia: A Case Report. Is "More" Always Better than "Less"? Deprescribing to Improve Patients' Clinical Outcomes: A Case Series. Buccal Transmucosal Controlled Drug Delivery System: Emerging Strategy For Oral Antidiabetic Therapy - A Review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1